Dedicated Investment Program II Will Further Eir Partners'
Strategy of Partnering with Companies Across the Healthcare
Technology & Technology Enabled Services Marketplace
MIAMI, May 21, 2024
/PRNewswire/ -- Eir Partners Capital, LLC ("Eir", "Eir Partners" or
the "Firm"), a middle market private equity firm focused on
healthcare technology and tech-enabled services, today announced
the final closing of Eir Partners Investment Program II with
$496 million in capital commitments.
Eir previously raised $255 million in
capital commitments for its inaugural program, Eir Partners Program
I, which closed in 2021 and invested in five platform
investments.
The oversubscribed program was raised in less than four months
and secured commitments from a diversified range of investors
including leading financial institutions, insurance companies,
family offices, funds-of-funds, endowments and foundations, and
seasoned industry executives.
"We are thrilled to receive support from a distinguished group
of investors to continue our strategy of partnering with
exceptional businesses and teams," said Brett Carlson, Founder & Chief Executive
Officer of Eir Partners. "Their commitment will help grow and
establish Eir as a leading health-tech investment firm in the
market."
Eir Partners Investment Program II will continue to invest in
disruptive companies that have proven market fit and scale
demonstrating outsized organic growth potential coupled with
accretive M&A opportunities. Eir seeks to partner with
businesses where the firm's operating experience and executive
advisor network can make an impact across all aspects of the
business including technology, finance, sales, and human
capital.
Lazard Frères & Co. LLC acted as the exclusive placement
advisor, and Kirkland & Ellis LLP served as legal counsel in
the formation of Eir Partners Investment Program II.
About Eir Partners
Eir Partners Capital, LLC is a Miami-based private equity company focused
exclusively on healthcare technology and tech- enabled services.
Eir combines its operational expertise with bottoms up thematic
sourcing efforts to accelerate value creation. Since
inception, Eir has completed transactions across payer, provider,
employer and pharma tech, including leading industry names such as
Apixio, Capta, GiftHealth, Helpware, and ReviveHealth. Targeted
stages of investment include growth equity through control buyouts
and equity check sizes range from $25
- $100 million.
For more information, please visit the Eir Partners website at
https://www.eirpartners.com/ or the Eir Partners LinkedIn page at
https://www.linkedin.com/company/eir-partners.
Contact
Chris Tofalli
Chris Tofalli Public Relations, LLC
914-834-4334
chris@tofallipr.com
View original
content:https://www.prnewswire.com/news-releases/eir-partners-closes-oversubscribed-496-million-investment-program-ii-302150277.html
SOURCE Eir Partners